Skip to content

Solesence, Inc. Common Stock SLSN Q1 2026 Annual earnings

Reported May 12, 2026 · After market close

Next report

Aug 6, 2026 (In 3 weeks)

Financials

Q1 2026

Income statement

See full
Revenue$13.0M-11.4%
Gross profit$3.3M-1.3%
Operating income-$504.0K-297%
Net income-$766.0K-1,058%
EPS (diluted)-$0.01

Balance sheet

See full
Cash & equivalents$573.0K-68.5%
Total debt$9.7M-3.3%
Total equity$17.0M+11.9%
Total assets$47.8M-16.2%

Cash flow

See full
Operating cash flow$1.5M+121%
CapEx$528.0K+497%
Free cash flow$989.0K+113%

Valuation & ratios

Valuation

as of 07/10/26
See full
Market cap$49.18M
Enterprise value$58.34M
P/E52.1×
P/S0.8×

Profitability

See full
Gross margin26.5%-1.5pp
Operating margin1.3%-6.5pp
Net margin1.6%

Returns & leverage

See full
Return on equity5.9%
Debt / equity0.6×-0.1×
Current ratio2.1×+1.0×

Segments

By product

See full
Consumer Products$10.0M-22.2%
Personal Care Ingredients$2.7M+98.5%
Advanced Materials$205.0K-44.6%

By geography

See full
Non Us$913.0K-8.1%

Versus estimates

Ask the moment Solesence, Inc. Common Stock reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Solesence, Inc. Common Stock report Q1 2026 earnings?
Solesence, Inc. Common Stock (SLSN) reported Q1 2026 earnings on May 12, 2026 after market close.
What were Solesence, Inc. Common Stock's Q1 2026 revenue and EPS?
Solesence, Inc. Common Stock reported revenue of $13.0M and diluted EPS of $-0.01 for Q1 2026.
How did Solesence, Inc. Common Stock's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 11.4% from $14.6M a year earlier.
Where can I find Solesence, Inc. Common Stock's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001171843-26-003273) and the 10-K periodic report (0001999371-26-007345) directly on SEC EDGAR. The filing index links above go to sec.gov.